Redmile Group »

Spdr S&p 500 Etf shares owned by Redmile Group

Quarter-by-quarter ownership of Spdr S&p 500 Etf (SPY) shares owned by Redmile Group from 13F filings

Historical chart of Redmile Group investment in Spdr S&p 500 Etf

Tip: Access up to 7 years of quarterly data

All positions including Spdr S&p 500 Etf held by Redmile Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spdr S&p 500 Etf by Redmile Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $68M 143k 475.31

More positions owned by Redmile Group

ImmunoGen
Krystal Biotech (KRYS)
Amicus Therapeutics (FOLD)
Scholar Rock Hldg Corp (SRRK)
Rayzebio
Augmedix (AUGX)
Deciphera Pharmaceuticals (DCPH)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Regenxbio Inc equity us cm (RGNX)
Biohaven (BHVN)
Zymeworks Del (ZYME)
Livanova SHS (LIVN)
Alx Oncology Hldgs (ALXO)
Catalent (CTLT)
Fate Therapeutics (FATE)

View all positions for Redmile Group

Top funds holding Spdr S&p 500 Etf

Citadel Advisors
Goldman Sachs Group
Bank of America Corporation
Jpmorgan Chase & Co
Wolverine Trading
Millennium Management
Royal Bank of Canada
HBK Investments
Barclays
Wells Fargo & Company
Walleye Trading Advisors
UBS Group
Gts Securities
Bank Of Montreal
CTC

View all funds holding Spdr S&p 500 Etf